{
  "@context": {
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/OPA1",
      "@type": "sc:SoftwareApplication",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_3334"
        },
        {
          "@id": "edam:topic_3512"
        },
        {
          "@id": "edam:topic_0625"
        }
      ],
      "sc:citation": [
        "pubmed:31500643",
        {
          "@id": "https://doi.org/10.1186/S13023-019-1187-1"
        },
        "pmcid:PMC6734442"
      ],
      "sc:description": "516 unique variants and 831 patients registered in an updated centralized Variome database | OPA1 (optic atrophy 1 (autosomal dominant)) | Autosomal dominant optic atrophy (DOA, Kjer type, MIM#165500) is characterized by moderate to severe loss of visual acuity with insidious onset in early childhood, blue-yellow dyschromatopsia and central scotoma",
      "sc:featureList": [
        {
          "@id": "edam:operation_3431"
        },
        {
          "@id": "edam:operation_0337"
        },
        {
          "@id": "edam:operation_3227"
        }
      ],
      "sc:name": "OPA1",
      "sc:url": "https://www.lovd.nl/OPA1"
    },
    {
      "@id": "https://doi.org/10.1186/S13023-019-1187-1",
      "@type": "sc:CreativeWork"
    }
  ]
}